Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2006
Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphologyArno Kornberg, Bernadett Küpper, Andrea Tannapfel, et al.BMC Surgery|January 30, 2013
The PRAISE study: a prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of iloprost in the early postoperative period after liver transplantation (ISRCTN12622749)Erik Bärthel, Falk Rauchfuss, Heike Hoyer, et al.Journal of Gastroenterology and Hepatology|November 23, 2007
Antiviral maintenance treatment with interferon and ribavirin for recurrent hepatitis C after liver transplantation: pilot studyArno Kornberg, Bernadett Küpper, Andrea Tannapfel, et al.Transplantation|August 14, 2008
Sustained clearance of serum hepatitis C virus-RNA independently predicts long-term survival in liver transplant patients with recurrent hepatitis CArno Kornberg, Bernadett Küpper, Andrea Tannapfel, et al.World Journal of Transplantation|September 30, 2016
Current techniques for AB0-incompatible living donor liver transplantationSilke Rummler, Astrid Bauschke, Erik Bärthel, et al.Transplantation|March 25, 2009
Combined en-bloc liver-pancreas transplantation in patients with liver cirrhosis and insulin-dependent type 2 diabetes mellitusArno Kornberg, Bernadett Küpper, Erik Bärthel, et al.Clinical Transplantation|September 17, 2011
Impact of stable PGI₂ analog iloprost on early graft viability after liver transplantation: a pilot studyErik Bärthel, Falk Rauchfuss, Heike Hoyer, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 15, 2011
Living donor liver transplantation in adults in the MELD era in Germany--a multi-center retrospective analysisUtz Settmacher, Max Götz, Axel Rahmel, et al.Pageof 1